unknown
Stage
2012
Founded
6
Investors
About
GenSight Biologics is a clinical-stage biotechnology company focused on developing gene therapies to treat neurodegenerative diseases leading to blindness through mitochondrial targeting and optogenetics technologies.
Explore GenSight's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.